Boston Common Asset Management, LLC Astrazeneca PLC Transaction History

Boston Common Asset Management, LLC

$1.8 Billion
Q4 2025

A detailed history of Boston Common Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 83,424 shares of AZN stock, worth $7.46 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

83,424

Previous 68,848 21.17%

Holding current value

$7.46 Million

Previous $5.28 Million 41.2%

% of portfolio

0.41%

Previous 0.3%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 15, 2026	BUY	$81.15 - $89.4 $1.18 Million - $1.3 Million	14,576 Added 21.17%	83,424 $7.46 Million
Q3 2025 Oct 30, 2025	SELL	$68.72 - $82.11 $34,016 - $40,644	-495 Reduced 0.71%	68,848 $5.28 Million
Q2 2025 Jul 22, 2025	SELL	$64.87 - $75.0 $154,066 - $178,125	-2,375 Reduced 3.31%	69,343 $4.85 Million
Q1 2025 Apr 03, 2025	BUY	$65.37 - $77.96 $1.09 Million - $1.29 Million	16,608 Added 30.14%	71,718 $5.27 Million
Q4 2024 Jan 15, 2025	SELL	$63.2 - $79.58 $496,436 - $625,100	-7,855 Reduced 12.48%	55,110 $3.61 Million

Q3 2024 Oct 09, 2024	SELL	$76.67 - $87.62 $250,174 - $285,904	-3,263 Reduced 4.93%	62,965 $4.91 Million
Q2 2024 Jul 08, 2024	SELL	$66.81 - $80.83 $165,287 - $199,973	-2,474 Reduced 3.6%	66,228 $5.17 Million
Q1 2024 Apr 11, 2024	BUY	$61.03 - $69.57 $71,832 - $81,883	1,177 Added 1.74%	68,702 $4.66 Million
Q4 2023 Jan 09, 2024	SELL	$61.89 - $69.28 $376,848 - $421,845	-6,089 Reduced 8.27%	67,525 $4.55 Million
Q3 2023 Oct 11, 2023	SELL	$64.85 - $71.7 $140,335 - $155,158	-2,164 Reduced 2.86%	73,614 $4.99 Million
Q2 2023 Jul 24, 2023	BUY	$69.91 - $75.81 $144,993 - $157,229	2,074 Added 2.81%	75,778 $5.42 Million
Q1 2023 May 17, 2023	BUY	$63.15 - $71.6 $461,815 - $523,610	7,313 Added 11.02%	73,704 $5.12 Million
Q4 2022 Jan 26, 2023	BUY	$54.21 - $70.44 $724,733 - $941,712	13,369 Added 25.21%	66,391 $4.5 Million
Q3 2022 Oct 20, 2022	BUY	$53.02 - $135.75 $761,579 - $1.95 Million	14,364 Added 37.16%	53,022 $2.91 Million
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $2.29 Million - $2.75 Million	38,658 New	38,658 $2.55 Million

Others Institutions Holding AZN

# of Institutions

1,528

Shares Held

502M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.

Account

Boston Common Asset Management, LLC Astrazeneca PLC Transaction History